327
Participants
Start Date
January 13, 2021
Primary Completion Date
May 20, 2022
Study Completion Date
February 27, 2023
AS012
oral administration
Placebo
oral administration
Sun Pharma Site 10, Ormond Beach
Sun Pharma Site 05, Miramar
Sun Pharma Site 04, Miami
Sun Pharma Site 06, Fort Lauderdale
Sun Pharma Site 14, West Lafayette
Sun Pharma Site 07, Troy
Sun Pharma Site 13, New Orleans
Sun Pharma Site 12, Baton Rouge
Sun Pharma Site 02, Bryant
Sun Pharma Site 03, Dallas
Sun Pharma Site 16, Pflugerville
Sun Pharma Site 15, Phoenix
Sun pharma site 30, Los Angeles
Sun Pharma Site 09, Fremont
Sun Pharma Site 11, Mill Creek
Sun Pharma Site 22, Chandigarh
Sun Pharma Site 27, Lucknow
Sun Pharma Site 18, Lucknow
Sun Pharma Site 17, Rājsamand
Sun Pharma Site 28, Rajkot
Sun Pharma Site 19, Ahmedabad
Sun Pharma Site 20, Gandhinagar
Sun Pharma Site 26, Pune
Sun Pharma Site 25, Nashik
Sun Pharma Site 21, Aurangabad
Sun Pharma Site 23, Bangalore
Sun PharmaSite 24, Mysuru
Sun Pharma Site 01, Brandon
Sun pharma site 31, Boston
Sun Pharma Site 29, East Greenwich
Sun Pharma Site 08, Warwick
Lead Sponsor
Ache Laboratorios Farmaceuticos S.A.
INDUSTRY